In conclusion, our findings indicate that overexpression of CLU can trigger the HSR by activating the PI3K/Akt pathway, thereby affording protection to cardiomyocytes from HT-induced apoptosis and inflammatory responses. The gene discussed is CLU; the disease is hematocrit.